Beacon Pointe Advisors, LLC
Position in BTAIQ — BioXcel Therapeutics, Inc.
CIK 1744317
NEWPORT BEACH, CA
Position in BTAIQ
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$26,560
+$1,265 QoQ
Shares Held
18,837
-0.2% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 47 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BTAIQ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $8,967,687 across 9 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
82,642 | $5,938,654 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,389 | $1,294,431 | |
| 3 | VTRS |
Viatris Inc
|
31,509 | $500,362 | |
| 4 | HROW |
Harrow, Inc.
|
7,596 | $322,602 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
16,724 | $268,085 | |
| 6 | HLN |
Haleon plc
|
27,933 | $260,614 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
60,500 | $251,680 | |
| 8 | TRLV |
Trulieve Cannabis Corp.
|
10,651 | $104,699 |
All Filings in BTAIQ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,560 | 18,837 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $25,295 | 18,877 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $34,109 | 18,845 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,255 | 18,845 | Shares | Sole | 2025-05-13 | |
| 2024-03-31 | — | 301,735 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | — | 301,735 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | — | 301,735 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | — | 302,150 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||